Sublingual immunotherapy for allergies.
D000286:Administration, Sublingual; D000485:Allergens / Q000009:adverse effects; D054598:Blue Cross Blue Shield Insurance Plans; D003888:Desensitization, Immunologic / Q000379:methods*; D017277:Drug Approval; D019317:Evidence-Based Medicine; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology / Q000628:therapy*; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D019458:Insurance Coverage; D017063:Outcome Assessment, Health Care; D013673:Technology Assessment, Biomedical; D014481:United States; D014486:United States Food and Drug Administration
D000485:Allergens; D007166:Immunosuppressive Agents